INDEGENE
Back to Cashflow Statement
|
INDEGENE Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹442 Cr | ₹508 Cr | ₹130 Cr | ₹297 Cr | ₹172 Cr |
What is the latest Cash Flow from Operating Activities ratio of INDEGENE ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹442 Cr |
| Mar2024 | ₹508 Cr |
| Mar2023 | ₹130 Cr |
| Mar2022 | ₹297 Cr |
| Mar2021 | ₹172 Cr |
How is Cash Flow from Operating Activities of INDEGENE Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹442 Cr | -12.96 | |
| Mar2024 | ₹508 Cr | 289.94 | |
| Mar2023 | ₹130 Cr | -56.17 | |
| Mar2022 | ₹297 Cr | 72.67 | |
| Mar2021 | ₹172 Cr | - | |
Compare Cash Flow from Operating Activities of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹11,851.1 Cr | 1.1% | 10.4% | -12.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | 0.3% | -3.7% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,817.0 Cr | 2.4% | 6.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,297.0 Cr | -0.8% | -1.5% | 25.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,828.0 Cr | 7.9% | 4.6% | 4.6% | Stock Analytics | |
| CIPLA | ₹104,588.0 Cr | 5.5% | 5.4% | -18.5% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | 1.1% |
10.4% |
-12.6% |
| SENSEX | -0.4% |
1.3% |
0.8% |
You may also like the below Video Courses